0001209191-22-031236.txt : 20220523
0001209191-22-031236.hdr.sgml : 20220523
20220523060942
ACCESSION NUMBER: 0001209191-22-031236
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220519
FILED AS OF DATE: 20220523
DATE AS OF CHANGE: 20220523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bagai Shaun
CENTRAL INDEX KEY: 0001862613
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40738
FILM NUMBER: 22949512
MAIL ADDRESS:
STREET 1: 4546 EL CAMINO REAL
STREET 2: SUITE 223
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RenovoRx, Inc.
CENTRAL INDEX KEY: 0001574094
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271448452
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 W. SANTA CLARA STREET, SUITE 900
CITY: SAN JOSE
STATE: CA
ZIP: 95110
BUSINESS PHONE: 408-800-2649
MAIL ADDRESS:
STREET 1: 333 W. SANTA CLARA STREET, SUITE 900
CITY: SAN JOSE
STATE: CA
ZIP: 95110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-19
0
0001574094
RenovoRx, Inc.
RNXT
0001862613
Bagai Shaun
C/O RENOVORX, INC.
4546 EL CAMINO REAL, SUITE B1
LOS ALTOS
CA
94022
1
1
0
0
Chief Executive Officer
Common Stock
2022-05-19
4
P
0
5500
2.05
A
251557
D
Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering.
/s/ Shaun Bagai
2022-05-23